HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Research Dictionary Pharma Mobile

Sign Up FREE or Login

(E)- ((3- cyclopentyloxy- 4- methoxyphenyl)methylene)- hydrazinecarboxamide

Subscribe to New Research on (E)-((3-cyclopentyloxy-4-methoxyphenyl)methylene)-hydrazinecarboxamide

a type IV phosphodiesterase inhibitor

Also Known As:

CJ-10882

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 58
- Hydrocarbons: 412
  - Cyclic Hydrocarbons: 3
    - Alicyclic Hydrocarbons: 1
      - Cycloparaffins: 5
        Cyclopentanes: 32
        (E)-((3-cyclopentyloxy-4-methoxyphenyl)methylene)-hydrazinecarboxamide: 1
- Hydrazines: 39
  - (E)-((3-cyclopentyloxy-4-methoxyphenyl)methylene)-hydrazinecarboxamide: 1

Experts

1.	Shin, Ho-Chul: 1 article (03/2004)
2.	Kim, Byungbae: 1 article (03/2004)
3.	Kim, Jong-Choon: 1 article (03/2004)
4.	Han, Junghee: 1 article (03/2004)

Related Diseases

1.	Vomiting 03/01/2004 - "The 4-week repeated oral doses of CJ-10882 resulted in salivation, vomiting, and atrophy of the thymus. "
2.	Atrophy 03/01/2004 - "The 4-week repeated oral doses of CJ-10882 resulted in salivation, vomiting, and atrophy of the thymus. "